Somnomed Ltd (SOM) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.083x

Based on the latest financial reports, Somnomed Ltd (SOM) has a cash flow conversion efficiency ratio of 0.083x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$4.15 Million ≈ $2.93 Million USD) by net assets (AU$50.04 Million ≈ $35.40 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Somnomed Ltd (SOM) defensive interval to measure how many days the company can operate on defensive assets alone.

Somnomed Ltd - Cash Flow Conversion Efficiency Trend (2004–2025)

This chart illustrates how Somnomed Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Somnomed Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Somnomed Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Kumpulan Kitacon Berhad
KLSE:5310
0.092x
CX Technology Corp
TW:2415
0.037x
Aesler Grup Internasional Tbk Pt
JK:RONY
-1.290x
Swift Haulage Bhd
KLSE:5303
0.048x
Chunghwa Chemical Synthesis & Biotech Co Ltd
TW:1762
0.028x
Alcadon Group AB
ST:ALCA
0.063x
Cosmax Nbt Inc
KQ:222040
0.204x
Codes Combine Co. Ltd
KQ:047770
-0.020x

Annual Cash Flow Conversion Efficiency for Somnomed Ltd (2004–2025)

The table below shows the annual cash flow conversion efficiency of Somnomed Ltd from 2004 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Somnomed Ltd.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$46.39 Million
≈ $32.82 Million
AU$7.78 Million
≈ $5.51 Million
0.168x +219.29%
2024-06-30 AU$45.02 Million
≈ $31.86 Million
AU$-6.33 Million
≈ $-4.48 Million
-0.141x +18.79%
2023-06-30 AU$22.40 Million
≈ $15.85 Million
AU$-3.88 Million
≈ $-2.75 Million
-0.173x -359.08%
2022-06-30 AU$27.79 Million
≈ $19.66 Million
AU$1.86 Million
≈ $1.31 Million
0.067x -20.55%
2021-06-30 AU$32.16 Million
≈ $22.75 Million
AU$2.71 Million
≈ $1.91 Million
0.084x -45.14%
2020-06-30 AU$33.84 Million
≈ $23.94 Million
AU$5.19 Million
≈ $3.67 Million
0.153x +141.74%
2019-06-30 AU$17.82 Million
≈ $12.61 Million
AU$-6.55 Million
≈ $-4.63 Million
-0.367x -27.15%
2018-06-30 AU$32.77 Million
≈ $23.19 Million
AU$-9.47 Million
≈ $-6.70 Million
-0.289x -233.80%
2017-06-30 AU$30.95 Million
≈ $21.90 Million
AU$-2.68 Million
≈ $-1.90 Million
-0.087x -234.43%
2016-06-30 AU$32.69 Million
≈ $23.13 Million
AU$2.11 Million
≈ $1.49 Million
0.064x +671.80%
2015-06-30 AU$21.51 Million
≈ $15.22 Million
AU$-242.22K
≈ $-171.39K
-0.011x +82.09%
2014-06-30 AU$12.57 Million
≈ $8.89 Million
AU$-790.41K
≈ $-559.26K
-0.063x -227.22%
2013-06-30 AU$11.57 Million
≈ $8.19 Million
AU$572.00K
≈ $404.73K
0.049x +52.14%
2012-06-30 AU$8.92 Million
≈ $6.31 Million
AU$289.78K
≈ $205.04K
0.032x +16.97%
2011-06-30 AU$6.22 Million
≈ $4.40 Million
AU$172.68K
≈ $122.18K
0.028x -65.99%
2010-06-30 AU$5.65 Million
≈ $4.00 Million
AU$461.46K
≈ $326.51K
0.082x +126.86%
2009-06-30 AU$4.33 Million
≈ $3.07 Million
AU$-1.32 Million
≈ $-932.16K
-0.304x +13.64%
2008-06-30 AU$6.01 Million
≈ $4.25 Million
AU$-2.12 Million
≈ $-1.50 Million
-0.352x +41.01%
2007-06-30 AU$3.91 Million
≈ $2.77 Million
AU$-2.34 Million
≈ $-1.65 Million
-0.597x +48.50%
2006-06-30 AU$3.23 Million
≈ $2.29 Million
AU$-3.75 Million
≈ $-2.65 Million
-1.159x -143.07%
2005-06-30 AU$7.20 Million
≈ $5.10 Million
AU$-3.43 Million
≈ $-2.43 Million
-0.477x -128.41%
2004-06-30 AU$-160.08K
≈ $-113.26K
AU$-268.63K
≈ $-190.07K
1.678x --

About Somnomed Ltd

AU:SOM Australia Medical Devices
Market Cap
$86.03 Million
AU$121.59 Million AUD
Market Cap Rank
#19836 Global
#652 in Australia
Share Price
AU$0.56
Change (1 day)
+0.91%
52-Week Range
AU$0.53 - AU$0.89
All Time High
AU$3.28
About

SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. It provides SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea. The company also offers SomMorning Repositioner, a product desig… Read more